Niche Focus Target neglected viral diseases with potential for partnerships in diagnostics, therapeutic development, and rapid-response testing solutions, aligning with Zalgen's expertise in hemorrhagic fevers and emerging pandemic threats.

Small Team Scale Leverage personalized outreach to a lean organization (2-10 employees) with high specialized knowledge; propose flexible collaboration models, pilot projects, and tight feedback loops to accelerate decision making.

Expansion Footprint Capitalize on the Frederick, Maryland presence to offer regional support services, regulatory navigation assistance, and on-site demonstrations for North American customers.

Diagnostics Pivot Position antibody testing capabilities for SARS-CoV-2 as a bridge to long-term partnerships in global infectious disease surveillance, serology platforms, and scalable assay development.

Financial Entry With modest revenue potential, emphasize cost-efficient, modular solutions and grant-friendly or cost-sharing procurement options to de-risk early engagement and foster joint funding opportunities.